SGA
Sector Gamma AS Portfolio holdings
AUM
$306M
This Quarter Return
+12.42%
1 Year Return
+4.68%
3 Year Return
+19.67%
5 Year Return
+46.47%
10 Year Return
+161.43%
AUM
$450M
AUM Growth
+$450M
(+5.2%)
Cap. Flow
-$20.1M
Cap. Flow
% of AUM
-4.48%
Top 10 Holdings %
Top 10 Hldgs %
56.42%
Holding
36
New
3
Increased
16
Reduced
10
Closed
6
Top Buys
| 1 |
Viatris
VTRS
|
$14.5M |
| 2 |
RAD
Rite Aid Corporation
RAD
|
$8.73M |
| 3 |
Masimo
MASI
|
$7.41M |
| 4 |
Baxter International
BAX
|
$6.02M |
| 5 |
HSP
HOSPIRA INC
HSP
|
$5.16M |
Top Sells
| 1 |
Eli Lilly
LLY
|
$15.3M |
| 2 |
CBST
CUBIST PHARMACEUTICALS INC
CBST
|
$13.3M |
| 3 |
Teva Pharmaceuticals
TEVA
|
$10.6M |
| 4 |
Edwards Lifesciences
EW
|
$9.69M |
| 5 |
THOR
THORATEC CORPORATION
THOR
|
$7.65M |
Sector Composition
| 1 | Healthcare | 91.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Baxter International
BAX
$12.7B
| $43.5M | 9.68% | 593,900 +82,100 | +16% | +$6.02M |
|
|
2
Eli Lilly
LLY
$657B
| $37.8M | 8.42% | 548,447 -221,700 | -29% | -$15.3M |
|
3
Boston Scientific
BSX
$156B
| $35.7M | 7.94% | 2,692,600 +145,000 | +6% | +$1.92M |
|
4
Stryker
SYK
$150B
| $23.6M | 5.24% | 249,683 +39,500 | +19% | +$3.73M |
|
5
Bristol-Myers Squibb
BMY
$96B
| $22.7M | 5.06% | 385,200 +68,200 | +22% | +$4.03M |
|
|
6
Edwards Lifesciences
EW
$47.8B
| $20.5M | 4.57% | 161,200 -76,100 | -32% | -$9.69M |
|
7
Revvity
RVTY
$10.5B
| $18.8M | 4.18% | 429,760 +32,300 | +8% | +$1.41M |
|
8
Ironwood Pharmaceuticals
IRWD
$214M
| $17.5M | 3.9% | 1,145,191 +6,900 | +0.6% | +$106K |
|
|
HSP
9
DELISTED
HOSPIRA INC
HSP
| $17.4M | 3.87% | 284,300 +84,300 | +42% | +$5.16M |
|
|
LPNT
10
DELISTED
LifePoint Health, Inc.
LPNT
| $16M | 3.57% | 222,900 +23,200 | +12% | +$1.67M |
|
11
Quest Diagnostics
DGX
$20.3B
| $15.7M | 3.5% | 234,628 -44,500 | -16% | -$2.98M |
|
|
12
Viatris
VTRS
$12.3B
| $14.5M | 3.22% | +256,600 | New | +$14.5M |
|
13
Cardinal Health
CAH
$35.5B
| $13.5M | 2.99% | 166,700 -33,300 | -17% | -$2.69M |
|
14
Tenet Healthcare
THC
$16.3B
| $13M | 2.9% | 257,500 +28,000 | +12% | +$1.42M |
|
|
THOR
15
DELISTED
THORATEC CORPORATION
THOR
| $12.7M | 2.83% | 392,500 -235,800 | -38% | -$7.65M |
|
16
Vertex Pharmaceuticals
VRTX
$100B
| $12.2M | 2.71% | 102,463 +28,000 | +38% | +$3.33M |
|
17
Bio-Rad Laboratories Class A
BIO
$8.06B
| $11.6M | 2.58% | 96,200 +19,100 | +25% | +$2.3M |
|
|
PDCO
18
DELISTED
Patterson Companies, Inc.
PDCO
| $11.4M | 2.54% | 237,465 -21,000 | -8% | -$1.01M |
|
|
WCG
19
DELISTED
Wellcare Health Plans, Inc.
WCG
| $11.1M | 2.46% | 134,745 -38,400 | -22% | -$3.15M |
|
20
Cencora
COR
$56.5B
| $10.1M | 2.26% | 112,500 +14,500 | +15% | +$1.31M |
|
21
Cigna
CI
$80.3B
| $9.67M | 2.15% | 94,000 +45,000 | +92% | +$4.63M |
|
|
22
Teva Pharmaceuticals
TEVA
$21.1B
| $8.99M | 2% | 156,300 -184,300 | -54% | -$10.6M |
|
23
Integra LifeSciences
IART
$1.18B
| $8.85M | 1.97% | 163,163 +48,972 | +43% | +$2.66M |
|
|
RAD
24
DELISTED
Rite Aid Corporation
RAD
| $8.73M | 1.94% | +1,161,000 | New | +$8.73M |
|
25
ResMed
RMD
$40.2B
| $8.09M | 1.8% | 144,300 -87,000 | -38% | -$4.88M |
|